Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Thomas R. Collins

Tom Collins is a freelance writer in South Florida, who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.

Articles by Thomas R. Collins

Pain Treatment Will to Become More Targeted as Knowledge of Pain Mechanics Increases

Thomas R. Collins  |  March 21, 2013

The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.

Tips for Myositis Management

Thomas R. Collins  |  March 19, 2013

Differentiating between subgroups of myositis is a diagnostic challenge for physicians, but using some guiding principles can be helpful,

Pain Treatment Will to Become More Targeted as Knowledge of Pain Mechanics Increases Bad

Thomas R. Collins  |  March 18, 2013

The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.

ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost

Thomas R. Collins  |  March 1, 2013

The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies

ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease

Thomas R. Collins  |  March 1, 2013

With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option

ACR/ARHP Annual Meeting 2012: Electronic Portals Appeal to Patients

Thomas R. Collins  |  March 1, 2013

A recent survey found that 75% of patients would use a secure electronic portal to access their medical information

ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults

Thomas R. Collins  |  March 1, 2013

Experts say children in pain from rheumatic diseases or other causes may have more discomfort because they can’t downregulate the pain as effectively as adults

Panel Addresses Drug Safety Issues in Rheumatology Products

Thomas R. Collins  |  February 15, 2013

Black box warnings, TNF inhibitors, and tofacitinib discussed

ACR/ARHP Annual Meeting 2012: How Rheumatologists Can Negotiate Better Contracts with Payers

Thomas R. Collins  |  February 1, 2013

Improving contracts with payers can earn rheumatologists more money, with no added costs in staffing or equipment

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

Thomas R. Collins  |  February 1, 2013

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs

  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences